California Appeals Court Reverses Summary Judgment In Diabetes Drug Case
LOS ANGELES — A California state appeals court on Nov. 6 reversed summary judgment for three drug makers in the state’s coordinated incretin mimetic diabetes drug litigation, saying the trial court...To view the full article, register now.
Already a subscriber? Click here to view full article